Durect share price today

(DRRX)

Durect share price is $0.97 & ₹82.64 as on 25 Dec 2024, 2.30 'hrs' IST

$0.97

▲

0.04

(4.44%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Durect share price in Dollar and Rupees. Guide to invest in Durect from India. Also see the sentimental analysis on Indian investors investing in Durect. Get details on the Indian mutual funds that are investing in Durect. Get Analyst recommendations and forecasts along with all the Durect's financials.

Durect share price movements

Today's Low: $0.89
Today's High: $0.97
$0.97
8.25%
Downside
Day's Volatility :8.25%
Upside
0.0%
52 Weeks Low: $0.51
52 Weeks High: $1.88
$0.97
47.64%
Downside
52 Weeks Volatility :72.98%
Upside
48.4%

Durect Returns

Period	Durect Corp	Russel 2000	Index (Russel 2000)
3 Months	-24.22%	0.0%	0.0%
6 Months	-28.94%	0.0%	0.0%
1 Year	84.76%	0.0%	0.0%
3 Years	-90.3%	-21.1%	-21.1%

Durect Key Statistics

in dollars & INR

Previous Close	$0.9288
Open	$0.89
Today's High	$0.97
Today's Low	$0.89
Market Capitalization	$28.8M
Today's Volume	$62.3K
52 Week High	$1.88
52 Week Low	$0.5079
Revenue TTM	$8.4M
EBITDA	$-24.9M
Earnings Per Share (EPS)	$-0.64
Profit Margin	-187.84%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-299.88%

How to invest in Durect from India?

It is very easy for Indian residents to invest directly in Durect from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Durect stock in both Indian Rupees (INR) and US Dollars (USD). Search for Durect or DRRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Durect or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Durect shares which would translate to 0.878 fractional shares of Durect as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Durect, in just a few clicks!

Returns in Durect for Indian investors in Rupees

Investment Value

₹1,00,000

Durect investment value today

Current value as on today

₹1,85,445

Returns

₹85,445

(+85.44%)

Returns from Durect Stock

₹83,019 (+83.02%)

Dollar Returns

₹2,426 (+2.43%)

Indian investors sentiment towards Durect

87%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Durect on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 87% more investors are searching Durect in the last 30 days versus the previous period.

Global Institutional Holdings in Durect

Ingalls & Snyder LLC
6.39%
Richmond Brothers Inc
3.68%
Vanguard Group Inc
3.67%
Gagnon Securities LLC
1.27%
Beirne Wealth Consulting Services, LLC
1.21%
Geode Capital Management, LLC
1.03%

Analyst Recommendation on Durect

Buy

70%Buy

30%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Durect(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Durect

What analysts predicted

Upside of 595.88%

Current:

$0.97

Target:

$6.75

Insights on Durect

Price Movement
In the last 7 days, DRRX stock has moved up by 14.9%
Decreasing Revenue
Revenue is down for the last 2 quarters, 2.17M → 1.92M (in $), with an average decrease of 11.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -3.7M → -4.28M (in $), with an average decrease of 15.8% per quarter

Durect Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$18.6M	↓ 62.25%
Net Income	$-25.3M	↑ 585.3%
Net Profit Margin	-136.4%	↓ 128.89%

	FY19	Y/Y Change
Revenue	$29.6M	↑ 59.25%
Net Income	$-22.8M	↓ 10.01%
Net Profit Margin	-77.08%	↑ 59.32%

	FY20	Y/Y Change
Revenue	$30.1M	↑ 1.85%
Net Income	$-2.5M	↓ 88.93%
Net Profit Margin	-8.38%	↑ 68.7%

	FY21	Y/Y Change
Revenue	$14.0M	↓ 53.58%
Net Income	$-38.1M	↑ 1411.7%
Net Profit Margin	-272.77%	↓ 264.39%

	FY22	Y/Y Change
Revenue	$19.3M	↑ 37.96%
Net Income	$-35.6M	↓ 6.66%
Net Profit Margin	-184.54%	↑ 88.23%

	FY23	Y/Y Change
Revenue	$8.5M	↓ 55.67%
Net Income	$-27.6M	↓ 22.37%
Net Profit Margin	-323.16%	↓ 138.62%

	Q2 FY23	Q/Q Change
Revenue	$2.1M	↑ 1.31%
Net Income	$-11.2M	↓ 8.55%
Net Profit Margin	-537.29%	↑ 57.94%

	Q3 FY23	Q/Q Change
Revenue	$1.7M	↓ 16.19%
Net Income	$-3.0M	↓ 73.03%
Net Profit Margin	-172.88%	↑ 364.41%

	Q4 FY23	Q/Q Change
Revenue	$2.7M	↑ 53.04%
Net Income	$-1.4M	↓ 52.21%
Net Profit Margin	-53.99%	↑ 118.89%

	Q1 FY24	Q/Q Change
Revenue	$1.8M	↓ 31.55%
Net Income	$-7.6M	↑ 430.4%
Net Profit Margin	-418.34%	↓ 364.35%

	Q2 FY24	Q/Q Change
Revenue	$2.2M	↑ 18.83%
Net Income	$-3.7M	↓ 51.59%
Net Profit Margin	-170.43%	↑ 247.91%

	Q3 FY24	Q/Q Change
Revenue	$1.9M	↓ 11.24%
Net Income	$-4.3M	↑ 15.81%
Net Profit Margin	-222.37%	↓ 51.94%

	FY18	Y/Y Change
Profit	$14.3M	↓ 66.38%

	FY19	Y/Y Change
Profit	$25.4M	↑ 77.76%

	FY20	Y/Y Change
Profit	$28.7M	↑ 12.92%

	FY21	Y/Y Change
Profit	$12.0M	↓ 58.12%

	FY22	Y/Y Change
Profit	$17.7M	↑ 47.19%

	FY23	Y/Y Change
Profit	$6.8M	↓ 61.4%

	Q2 FY23	Q/Q Change
Profit	$1.7M	↑ 3.36%

	Q3 FY23	Q/Q Change
Profit	$1.4M	↓ 16.84%

	Q4 FY23	Q/Q Change
Profit	$2.0M	↑ 40.43%

	Q1 FY24	Q/Q Change
Profit	$1.5M	↓ 23.52%

	Q2 FY24	Q/Q Change
Profit	$1.8M	↑ 18.01%

	Q3 FY24	Q/Q Change
Profit	$1.4M	↓ 22.09%

	FY18	Y/Y Change
Operating Cash Flow	$-19.8M	↑ 1370.59%
Investing Cash Flow	$4.5M	↓ 64.25%
Financing Cash Flow	$17.5M	↑ 38.48%

	FY19	Y/Y Change
Operating Cash Flow	$11.1M	↓ 156.21%
Investing Cash Flow	$-27.3M	↓ 702.25%
Financing Cash Flow	$19.5M	↑ 11.56%

	FY20	Y/Y Change
Operating Cash Flow	$-38.7M	↓ 448.65%
Investing Cash Flow	$9.4M	↓ 134.52%
Financing Cash Flow	$15.7M	↓ 19.7%

	FY21	Y/Y Change
Operating Cash Flow	$-37.3M	↓ 3.6%
Investing Cash Flow	$15.3M	↑ 62.33%
Financing Cash Flow	$50.5M	↑ 222.68%

	FY22	Y/Y Change
Operating Cash Flow	$-26.3M	↓ 29.57%
Investing Cash Flow	$19.8M	↑ 29.55%
Financing Cash Flow	$83.0K	↓ 99.84%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-9.3M	↑ 0.86%
Investing Cash Flow	$1.8M	↓ 137.39%
Financing Cash Flow	$-34.0K	↓ 100.34%

Durect Technicals Summary

Sell

Neutral

Buy

Durect is currently in a neutral trading position according to technical analysis indicators.

Durect Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Durect Corp	0.0%	-28.94%	84.76%	-90.3%	-97.25%
Neurocrine Biosciences Inc.	6.74%	1.65%	2.84%	61.59%	27.41%
Haleon Plc Spon Ads	1.56%	15.54%	17.63%	31.44%	31.44%
Zoetis Inc.	-6.26%	-6.66%	-16.35%	-33.19%	24.57%
Viatris Inc.	-5.2%	18.32%	15.13%	-9.29%	-24.11%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Durect Corp	NA	NA	-0.46	-0.5	-3.0	-0.4	NA	0.49
Neurocrine Biosciences Inc.	36.41	36.41	0.32	6.37	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	29.45	29.45	1.76	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	30.88	30.88	2.56	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.08	2.69	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Durect Corp	Buy	$28.8M	-97.25%	NA	-187.84%
Neurocrine Biosciences Inc.	Buy	$13.8B	27.41%	36.41	17.21%
Haleon Plc Spon Ads	Buy	$43.9B	31.44%	29.45	10.75%
Zoetis Inc.	Buy	$74.1B	24.57%	30.88	26.55%
Viatris Inc.	Hold	$14.9B	-24.11%	224.4	-5.87%

About Durect

durect is a specialty pharmaceuticals company with expertise in drug discovery, drug delivery and drug development, applying those skills primarily to therapeutics in the fields of pain management, acute organ injury and metabolic diseases. durect’s proprietary oral, transdermal and injectable depot delivery technologies enable new indications and superior clinical/commercial attributes such as improved abuse deterrence, convenience, adherence, efficacy and safety for small molecule and biologic drugs. late stage development programs of this nature include remoxy® and posidur™. durect’s epigenomic regulator program includes the lead molecule dur-928 in phase 1 clinical testing. dur-928 is an endogenous small molecule that is an epigenomic modulator of cellular activities involved in lipid homeostasis, metabolic disease, inflammation and cell survival. for more information, please visit www.durect.com. we also manufacture and sell two commercial product lines: • alzet® osmotic pumps use

Organization	Durect
Employees	48
CEO	Dr. James E. Brown D.V.M.
Industry	Health Technology

Management People of Durect

Name	Title
Dr. James E. Brown D.V.M.	Co-Founder, CEO, President & Director
Mr. Timothy M. Papp M.B.A.	CFO & Secretary
Dr. Norman L. Sussman M.D.	Chief Medical Officer
Ms. Judy R. Joice	Senior Vice President of Operations & Corporate Quality Assurance
Dr. WeiQi Lin M.D., Ph.D.	Executive VP of Research & Development and Principal Scientist
Ms. Jian Li M.B.A.	Senior VP of Finance, Corporate Controller & Secretary
Dr. Su Il Yum Ph.D.	Executive Officer

Important FAQs about investing in Durect from India :

What is Durect share price today?

Durect share price today stands at $0.97, Open: $0.89 ; Previous Close: $0.93 ; High: $0.97 ; Low: $0.89 ; 52 Week High: $1.88 ; 52 Week Low: $0.51. The stock opens at $0.89, after a previous close of $0.93. The stock reached a daily high of $0.97 and a low of $0.89, with a 52-week high of $1.88 and a 52-week low of $0.51.

Can Indians buy Durect shares?

Yes, Indians can invest in the Durect (DRRX) from India.

With INDmoney, you can buy Durect at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Durect at zero transaction cost.

How can I buy Durect shares from India?

It is very easy to buy Durect from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Durect be purchased?

Yes, you can buy fractional shares of Durect with INDmoney app.

What are the documents required to start investing in Durect stocks?

To start investing in Durect, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.